Trial design and participants
esophageal and gastric cardia cancers
This was a single center, parallel designed (1:1), single-blind randomized placebo-controlled trial performed on patients with esophageal and gastric cardia cancers who were referred to the radiation oncology clinic of the Vali-E-asr Hospital, Zanjan, Iran, from September 2020 to December 2021.